Ardelyx, Inc. (ARDX) stock
Close on Nov 17, 2026Market cap $792.42MP/E –Yield –
Earnings
Ardelyx's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Ardelyx's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 18, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 3, 2026after the close | $125.50M | +13.8% | $0.00 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026during market hours | – | – | -$0.07 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026during market hours | $94.47M | +27.5% | -$0.15 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 19, 2026during market hours | $125.22M | +7.8% | $0.00 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 30, 2025during market hours | $110.30M | +12.3% | $0.00 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 4, 2025during market hours | $97.70M | +33.5% | -$0.08 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025during market hours | $74.10M | +61.1% | -$0.17 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 20, 2025before the open | $116.13M | +237.9% | $0.02 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 31, 2024during market hours | $98.20M | +74.1% | $0.00 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024during market hours | $73.20M | +228.3% | -$0.07 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024during market hours | $46.00M | +304.6% | -$0.11 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 22, 2024during market hours | $34.36M | -22.2% | -$0.12 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 31, 2023before the open | $56.40M | – | $0.03 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023before the open | $22.30M | +782.8% | -$0.08 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023during market hours | $11.37M | +2329.3% | -$0.13 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 2, 2023during market hours | $44.18M | +4193.3% | $0.06 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022during market hours | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022during market hours | $2.53M | – | -$0.19 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022during market hours | $468.00K | – | -$0.21 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 28, 2022during market hours | $1.03M | – | -$0.31 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 12, 2021before the open | $1.20M | – | -$0.42 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 19, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021before the open | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 8, 2021before the open | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Ardelyx's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue guidance for IBSRELA | FY2026 | $350.00M – $370.00M | $410.00M – $430.00M | Raised | Nov 3, 2026 |
| revenue guidance for IBSRELA | FY2026 | $350.00M – $370.00M | $410.00M – $430.00M | Raised | Aug 6, 2026 |
| operating expense guidance | FY2026 | $500.00M | – | New | Nov 3, 2026 |
| OPEX guidance | FY2026 | $500.00M | – | New | Aug 6, 2026 |
| annual revenue | FY2029 | $1.00B | – | New | Feb 19, 2026 |
Guidance vs results
The last range Ardelyx gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $270.00M – $275.00M | $407.32MΣ4Q | Above range |
Guidance history
Every forecast Ardelyx put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 3, 2026 | operating expense guidance | FY2026 | $500.00M | New |
| Nov 3, 2026 | revenue guidance for IBSRELA | FY2026 | $350.00M – $370.00M | Raised |
| Nov 3, 2026 | annual revenue | long-term | $1.00B | – |
| Nov 3, 2026 | revenue guidance for XPHOZAH | FY2026 | $110.00M – $120.00M | Lowered |
| Aug 6, 2026 | OPEX guidance | FY2026 | $500.00M | New |
| Aug 6, 2026 | IBSRELA long-term guidance | long-term | $1.00B | – |
| Aug 6, 2026 | revenue guidance for IBSRELA | FY2026 | $350.00M – $370.00M | Raised |
| Aug 6, 2026 | revenue guidance for XPHOZAH | FY2026 | $110.00M – $120.00M | Lowered |
| Apr 30, 2026 | IBSRELA revenue | FY2026 | $410.00M – $430.00M | New |
| Apr 30, 2026 | XPHOZAH revenue | FY2026 | $110.00M – $120.00M | Lowered |
| Feb 19, 2026 | annual revenue | FY2029 | $1.00B | New |
| Feb 19, 2026 | revenue for IBSRELA | FY2026 | $410.00M – $430.00M | New |
| Feb 19, 2026 | XPHOZAH revenue | FY2026 | $110.00M – $120.00M | Lowered |
| Oct 30, 2025 | IBSRELA revenue | FY2025 | $270.00M – $275.00M | New |
| Aug 4, 2025 | IBSRELA net sales revenue | FY2025 | $250.00M – $260.00M | Raised |
| May 1, 2025 | U.S. net product sales revenue for IBSRELA | FY2025 | $240.00M – $250.00M | Reaffirmed |
| Feb 20, 2025 | U.S. net product sales revenue for IBSRELA | FY2025 | $240.00M – $250.00M | New |
| Oct 31, 2024 | U.S. net product sales revenue for IBSRELA | FY2024 | $145.00M – $150.00M | Raised |
| Aug 1, 2024 | U.S. net product sales revenue for IBSRELA | FY2024 | $140.00M – $150.00M | Reaffirmed |
| May 2, 2024 | U.S. net product sales revenue for IBSRELA | FY2024 | $140.00M – $150.00M | Reaffirmed |
| Feb 22, 2024 | U.S. net product sales revenue for IBSRELA | FY2024 | $140.00M – $150.00M | New |
| Oct 31, 2023 | U.S. net product revenue for IBSRELA | FY2023 | $76.00M – $78.00M | Raised |
| Aug 2, 2023 | net product revenue for IBSRELA | FY2023 | $72.00M – $77.00M | New |
| Nov 3, 2022 | milestone payments and payments associated with the 2022 amendment of the license agreement | Q4 FY2022 | $35.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Ardelyx filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?